Candelaria McElhinny, RPAC

Candelaria McElhinny practices at Breast Care of Western New York in Buffalo, New York.

Candelaria McElhinny's NPI, 1922363274, was assigned on July 11, 2012. Candelaria McElhinny holds New York license 0156731.

Candelaria McElhinny's primary practice is Breast Care of Western New York, at 199 Park Club Ln, Buffalo, NY 14221 in Erie County. The practice phone is (716) 634-3340.

Candelaria McElhinny's primary practice is Breast Care of Western New York in Buffalo, New York. Candelaria McElhinny is also affiliated with Sisters of Charity Hospital. The medical group on file is Breast Care of Western New York. Dmand AI also links Candelaria McElhinny to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Candelaria McElhinny practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Candelaria McElhinny's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Candelaria McElhinny is licensed in New York.

CMS data shows 495 Medicare services from Candelaria McElhinny across 7 procedure codes in 2024, for 119 Medicare patients. Medicare paid $14,003 for them. Every service was in an office.

CMS counts 119 Medicare patients who saw Candelaria McElhinny in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have cancer, and 73% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Candelaria McElhinny's median patient age at 66, with 96% women.

In 2024, Candelaria McElhinny wrote 1,257 Medicare Part D claims for 323 patients. 89% of them were for generic drugs. CMS names the drug for 1,080 of them, across 16 drugs with 11 or more claims each, at $1,400,996 in total drug cost.

Candelaria McElhinny accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 63 general payments to Candelaria McElhinny from 23 drug and device companies in 2025. Food and beverage make up the largest share, 53% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,187.